Tag Archives: China

Pharma's Reputation: A Boost in the US, but China Strikes a Sour Note

The pharmaceutical industry’s global reputation is on the mend, even if some countries – notably China – are more hostile, according to the latest Ipsos Reputation Snapshot for the Pharmaceutical Sector, from the Ipsos Global Reputation Centre. Since the last Ipsos survey in 2008, pharma’s reputation has improved significantly in the US, more so than […]
Posted in Corporate Responsibility, Emerging Markets, Safety, Strategy | Tagged | Leave a comment

SciClone Pharmaceuticals: Selling Specialty Drugs in China

US-based SciClone Pharmaceuticals has built its business around selling specialty drugs in China. Companies like Sanofi and Pfizer, despite their own in-country resources, have partnered with SciClone and are achieving better returns, according to SciClone CEO Friedhelm Blobel.
Posted in Biotech, compliance, Emerging Markets, Global, healthcare, IP, Legal, Manufacturing, People, pricing, Regulatory, Sales, Strategy | Also tagged , | 1 Comment

Tasty Asian Acquisition for Publicis

Publicis Healthcare Gobbles Up Another Asian Agency Publicis continues its expansion into Asia with today’s (Feb 20) announcement of its acquisition of U-Link Business Solutions (UBS), one of China’s leading agencies specializing in healthcare communications. As a part of Publicis Healthcare Communications Group, the agency will be renamed UBS Saatchi & Saatchi Health. “The Chinese […]
Posted in Agency Insight, Emerging Markets, Global, Guest Blog | Also tagged , , , | Leave a comment

California Life Sciences to Partner with China

BIOCOM, a trade group representing Southern California’s life sciences industry, is ramping up partnership efforts in China to meet an emerging desire for novel drug therapies. While intellectual property (IP) protections and the Chinese government’s willingness to pay for expensive new products represent two large and lingering question marks, Joe Panetta, president and CEO at […]
Posted in Biotech, Emerging Markets, Global, IP, leadership, Market Access, R&D | Also tagged , , , | Leave a comment

New Decade, New Agenda for Pharma

A new track for nonprofits, product diversification and the rise of the emerging markets —  Audrey S. Erbes reports on some of the takeaways from this week’s JP Morgan Healthcare Conference. There were some surprising changes in the format of the 29th Annual JP Morgan Healthcare Conference, the world’s premier health care industry investment meeting […]
Posted in Emerging Markets, Guest Blog, R&D | Also tagged , , , , | Leave a comment
  • Categories

  • Meta